Sleep Apnea and Cognitive Dysfunction in Myasthenia Gravis

Acta Medica Austriaca

Volumn 24, Issue 3, 1997, Pages 128-131

  Stepansky, R ^a   Weber, G ^a   Zeitlhofer, J ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

CNS; Cognitive function; Myasthenia gravis; REM; Sleep apnea

Indexed keywords

ADULT; ARTICLE; ATTENTION; BRAIN; COGNITIVE DEFECT; FEMALE; HUMAN; LUNG VENTILATION; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYSOMNOGRAPHY; RECALL; REM SLEEP; SLEEP APNEA SYNDROME; SLEEP STAGE;

ADULT; ATTENTION; BRAIN; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MENTAL RECALL; MIDDLE AGED; MYASTHENIA GRAVIS; NEUROPSYCHOLOGICAL TESTS; POLYSOMNOGRAPHY; PULMONARY VENTILATION; SLEEP APNEA SYNDROMES; SLEEP STAGES; SLEEP, REM;

EID: 0030630231     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Adornato BT, Houff SA, Engel WK, Dalakas M, Madden DL, Sever JL: Abnormal immunglobulinbands in cerebrospinal fluid in myasthenia gravis. Lancet 1978;II:367-368.
2. Bedard MA, Montplaisir J, Richer F, Malo J: Nocturnal Hypoxemia as a Determinant of Vigilance Impairment in Sleep Apnea Syndrome. Chest 1991;100:367-370.
3. Crowley JS. Wesenstein N, Kamimori G, Devine J, Iwanyk E, Balkin T: Effect of High Terrestrial Altitude and Supplemental Oxygen on Human Performance and Mood. Aviat Space Environ Med 1992;63:696-701.
4. Curro Dossi R, Pare D, Steriade M: Short-Lasting Nicotinic and Long -Lasting Muscarinic Depolarizing Responses of Thalamocortical Neurons to Stimulation of Mesopontine Cholinergic Nuclei. J Neurophysiol 1991;65:393-406.
5. Dunnet SB, Fibiger HC: Role of cholinergic systems in learning and memory. Prog Brain Res 1993;98:413-420.
6. Fulpius BW, Fontana A, Cuenod S: CNS involvement in experimental autoimmune myasthenia gravis. Lancet 1977;2:350-351.
7. Gerber WD, Diener HC: Klinisch-psychologische und neuropsychologische Untersuchungen zur Myasthenia gravis. In Jacobi P (ed): Jahrbuch der medizinischen Psychologie Bd 2: Psychologie in der Neurologie. Berlin-Heidelberg-New York-London-Paris-Tokyo-Hong Kong, Springer, 1989, pp 185-200.
8. Gillin JC, Salin Pascual R, Velazquez-Moctezuma J, Shiromani P, Zoltoski R: Cholinergic receptor subtypes and REM-sleep in animals and normal controls. Prog Brain Res 1993;98:379-387.
9. Grant I, Heaton RK, MC Sweeny AJ, Adams KM, Timms RM: Brain dysfunction in COPD. Chest 1980;77:308-309.
10. Greenberg GD, Watson RK, Deptula D: Neuropsychological Dysfunction in Sleep Apnea. Sleep 1987;10:254-262.
11. Henkes H, Jager H, Dewes W, Hierholzer J, Piepgras U: MRT und 99mTc-HM-PAO SPECT des Gehirns bei Myasthenia gravis. Bildgebung 1991;58:208-214.
12. Iwasaki Y, Kinoshita M, Ikeda K, Shiojimat, Kurihara T: Neuropsychological function before and after plasma exchange in myasthenia gravis. J Neurol Sci 1993;114:223-226.
13. Jäger AO, Althoff K: Der Wilde Intelligenztest (WIT). Ein Strukturdiagnostikum. Göttingen-Toronto-Zürich. Hogrefe, 1983.
14. Keesy JC, Tourtellotte WW, Herrmann C jr, Andrews JM, Lindstrom JM: Acetylcholine-receptor antibody in cerebrospinal fluid. Lancet 1978;1:777.
15. Lefvert AK, Pirskanen R: Aceylcholine-receptorantibodies in cerebrospinal fluid in myasthenia gravis. Lancet 1977;II:351-352.
16. Levin ED: Nicotinic systems and cognitive function. Psychopharmacology 1992;108:417-431.
17. Lewis SW, Maron, Newsom Davis J: Absence of central functional cholinergic deficits in myasthenia gravis. J Neurol Neurosurg Psychiatry 1989; 52:258-261.
18. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane D: Antibody to acetylcholine receptor in myasthenia gravis. Neurology 1976;26: 1054-1059.
19. Lützenkirchen J: Zur Psychosomatik der Myasthenie. Z Psychosom Med Psychoanal 1977;23:363-370.
20. Meier-Ewert K: Tagesschläfrigkeit: Ursachen, Differentialdiagnose, Therapie. In Neudörfer B, Schimey K, Soyka D (Hrsg): Praktische Neurologie. Weinheim, Edition Medizin, 1989.
21. Meier-Ewert K: Abnorme Tagesschläfrigkeit - Ansätze zu einer Typologie. Ther Rundsch 1991;48:746-750.
22. Mertens H G, Lützenkirchen J, Hertel G: Psychologische Probleme bei der Behandlung von Myastheniekranken. Nervenarzt 1976;47:517-519.
23. Montplaisier J, Bedard MA, Richer F, Rouleau I: Neurobehavioral Manifestations in Obstructive Sleep Apnea Syndrom before and after Treatment with Continous Positive Airpressure. Sleep 1992;15:17-19.
24. Nabeshima T: Behavioral aspects of cholinergic transmission: role of basal forebrain cholinergic system in learning and memory. Prog Brain Res 1993;98:405-411.
25. Newhouse PA, Potter A, Corwin J, Lenox R: Acute nicotinic blockade produces cognitive impairment in normal humans. Psychopharmacol 1992;108:480-484.
26. Noble J, Jones JG, Davis EJ: Cognitive Function During Moderate Hypoxemia. Anaesth Intensive Care 1993;21:180-184.
27. 11C-Nicotine in brain of Alzheimer patients as visualized by positron emission tomography. J Neural Transm 1990;2:215-224.
28. Papazian O: Rapid eye movement sleep alterations in myasthenia gravis. Neurology 1976;26:311-316.
29. Quera-Salva MA, Guilleminault C, Chevret S, Troche G, Fromageot C, Crowe C, Stoos R, De Lattre J, Raphael JC, Gajdos PH: Breathing Disorders during Sleep in Myasthenia Gravis. Ann Neurol 1991;31:86-92.
30. Rechtschaffen A, Kales A: A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles, Brain information Service, 1968.
31. Saletu B, Grünberger J, Anderer P: Proof of Antihypoxidotic Properties of Tenilsetam in Man by EEG and Psychometric Analyses Under an Experimental Hypoxic Hypoxidosis. Drug Develop Res 1987;10:135-155.
32. Saletu B, Wessely P, Grunberger J. Schultes M: Erste klinische Erfahrungen mit einem neuen schlafanstoßenden Benzodiazepain Cinolazepam mittels eines Selbstbeurteilungsbogens für Schlaf und Aufwachqualität (SSA). Neuropsychiatrie 1987;1:169-176.
33. Saphier D, Birmanns B, Brenner T: Electroencephalographic changes in experimental autoimmune myasthenia gravis. J Neurol Sci 1993;114:200-204.
34. Shiozawa Z, Shintani S, Tsunoda S, Shindo K: Sleep apnea in well controlled myasthenia gravis. Sleep Res 1987;16:301.
35. Shiozawa Z, Amino A, Mineno M, Shindo K, Tsunoda S, Shintani S: Sleep apnea in well controlled myasthenia gravis (second report). Sleep Res 1993;22:272.
36. Snead OC, Benton JW, Dwyer D, Morley BJ, Kemp GE, Bradley RJ, Oh S: Juvenile myasthenia gravis. Neurology 1980;30:732-739.
37. Tucker DM, Roeltgen DP, Wann PD, Wertheimer RI: Memory dysfunction in myasthenia gravis: Evidence for central cholinergic effects. Neurology 1988;38:1173-1177.
38. Wechsler D: A standardized memory scale for clinical use. J Psychol 1945;19:87-95.
39. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, De Long MR: Alzheimer's disease and senile dementia - loss of neurons in the basal forebrain. Science 1982;215:237-1239.
40. Whitehouse PJ, Martino AM, Wagster MV, Price DL, Mayeux R, Kellar KJ: Reductions in nicotinic acetylcholine binding in Alzheimers disease and Parkinsons disease. Neurology 1988;38:720-723.
41. Whiting PJ, Cooper J, Lindstrom JM: Antibodies in sera from patients with myasthenia gravis do not bind to nicotinic acetylcholine receptors from human brain. J Neuroimmunol 1987;16:205-213.
42. Woolf NJ: Cholinergic Systems in Mammalian Brain and Spinal Cord. Prog Neurobiol 1991;37:475-524.
43. Zerssen DV, Koeller DM, Rey ER: Die Befindlichkeitsskala (BS) - ein einfaches Instrument zur Objektivierung von Befindlichkeitsstörungen, insbesondere im Rahmen von Längsschnittsuntersuchungen. Arzneimittel Forsch 1970;29:915-918.